Atlanta, GA, October 21, 2002 --- Blake Whitney, chairman, president and chief executive officer of MDdatacor, inc., a medical informatics company that rapidly identifies patient populations for clinical trials, approved therapeutics and medical devices, will present at Lifescience Portfolio 2002, an annual investment conference produced by the publishers of VentureWire and Venture Finance. The event will be held October 21-22, 2002 in San Francisco.

Mr. Whitney was asked to speak at the conference after MDdatacor was selected as being among "the best crop of life science investment and partnership prospects as reviewed by the editors and researchers at VentureWire Lifescience." Companies are invited to make presentations on their technologies, management teams, business momentum and prospects. The conference attracts an audience of over three hundred venture capitalists and senior healthcare and pharmaceutical executives each year.

"I am honored to introduce MDdatacor to this influential group of healthcare and venture capital decision makers," says Mr. Whitney. "For MDdatacor to be identified as one of 'the hottest emerging companies in the Lifescience market segment' one year after our initial capitalization is a testament to the extraordinary value our services provide physicians and the healthcare industry."